CSTF3: A Protein Involved in Cell Signaling Pathways and Tissue Development

Target Name: CSTF3

NCBI ID: G1479

CSTF3

Other Name(s): cleavage stimulation factor, 3' pre-RNA, subunit 3, 77kD | cleavage stimulation factor 77 kDa subunit | cleavage stimulation factor subunit 3 | CSTF 77 kDa subunit | Cleavage stimulation factor subuni

CSTF3: A Protein Involved in Cell Signaling Pathways and Tissue Development

Cleavage stimulation factor (CSF), also known as CSTF3, is a protein that plays a crucial role in the development and maintenance of tissues in the body. It is a key regulator of cell signaling pathways that are involved in various physiological processes, including cell growth, differentiation, and survival. In recent years, researchers have discovered that CSTF3 is involved in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. As a result, CSTF3 has become a promising drug target and biomarker for a variety of diseases.

CSF is a transmembrane protein that is expressed in a variety of tissues throughout the body, including the brain, pancreas, and skin. It is a single-pass RNA molecule that is synthesized from a pre-mRNA through a process called cleavage by the enzyme trypsin. The pre-mRNA is derived from the cytoplasm of the target cell, and the trypsin cleavage event creates a 77kDa protein that is then released into the cytoplasm. This protein is involved in the regulation of various cellular processes, including cell signaling pathways, DNA replication, and apoptosis.

One of the key functions of CSTF3 is its role in cell signaling pathways. It is a negative regulator of the TGF-β pathway, which is involved in cell growth, differentiation, and survival. The TGF-β pathway is a well-established cancer-promoting pathway that is involved in the development of many types of cancer, including breast, lung, and colorectal cancers. CSTF3 has been shown to play a negative role in the TGF-β pathway by regulating the activity of the transcription factor Smad, which is a key player in the pathway.

In addition to its role in cell signaling pathways, CSTF3 is also involved in the regulation of DNA replication. It is a component of the DNA replication machinery and has been shown to play a role in the regulation of DNA replication in various cell types. CSTF3 has been shown to interact with the enzyme responsible for DNA replication, called DNA polymerase II (DNA-PSI), and to regulate its activity. This interaction between CSTF3 and DNA-PSI suggests that CSTF3 may be involved in the regulation of DNA replication in cancer cells.

CSF is also involved in the regulation of apoptosis, which is a process that is involved in cell death and is critical for the development and maintenance of tissues. CSTF3 has been shown to play a role in the regulation of apoptosis by regulating the activity of the transcription factor p53, which is a key player in the process.

In conclusion, CSTF3 is a protein that is involved in a number of cellular processes that are critical for the development and maintenance of tissues. Its role in cell signaling pathways, DNA replication, and apoptosis makes it an attractive drug target and biomarker for a variety of diseases. Further research is needed to fully understand the role of CSTF3 in these processes and to develop effective therapies for a variety of diseases.

Protein Name: Cleavage Stimulation Factor Subunit 3

Functions: One of the multiple factors required for polyadenylation and 3'-end cleavage of mammalian pre-mRNAs

The "CSTF3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CSTF3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets